163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study
Titel:
163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study
Auteur:
Chan, A.T.C. Lee, H.F.V. Hong, R-L. Ahn, M-J. Chong, W.Q. Kim, S-B. Fuang, H.G. Caguioa, P.B. Ngamphaiboon, N. Ho, C. Abdul Aziz, M.A.S. Ng, Q.S. Yen, C.J. Soparattanapaisarn, N. Ngan, R. Kho, S.K. Wang, L. Swaby, R. Saraf, S. Siu, L.L.